2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Classical hematology
1
CNS
1
Conditions
Pain
16
Cancer Pain
14
Neoplasms
13
Agnosia
3
Prostatic Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Neuralgia
2
Neoplasm Metastasis
2
Multiple Myeloma
2
Lymphoma, Follicular
2
Lymphoma
2
Inflammation
2
Head and Neck Neoplasms
2
Bronchiolitis Obliterans Syndrome
2
Acute Pain
2
Waldenstrom Macroglobulinemia
1
Urinary Tract Infections
1
Trigger Finger Disorder
1
Thrombocythemia, Essential
1
Stomatitis
1
Staphylococcal Infections
1
Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8
1
Squamous Cell Carcinoma of Head and Neck
1
Spasm
1
Sleep Initiation and Maintenance Disorders
1
Sezary Syndrome
1
Sepsis
1
Seizures
1
Schizophrenia, Treatment-Resistant
1
Schizophrenia
1
Interventions
pegfilgrastim
30
Filgrastim
29
Cyclophosphamide
10
pegylated granulocyte colony-stimulating factor
8
Docetaxel
8
Etoposide
7
Cytarabine
7
Ciprofloxacin
6
Cefepime
6
Vancomycin
5
Leucovorin
5
Fluorouracil
5
eflapegrastim
4
Granulocyte Colony-Stimulating Factor
4
Doxorubicin
4
Peripheral Blood Stem Cell Transplantation
3
Mitoxantrone
3
Methotrexate
3
Levofloxacin
3
Irinotecan
3
Idarubicin
3
Daunorubicin
3
Cyclosporine
3
Caspofungin
3
Carboplatin
3
Amikacin
3
trifluridine tipiracil drug combination
2
plerixafor
2
liposomal amphotericin B
2
Vincristine
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neutropenia
×
Oxycodone
×
Clear all
NCT01431326
2023-09-06
PTN_POPS
Duke University
Completed
3,520 enrolled